Portrayal of a person with migraine

Thought it wouldn’t be a full-blown migraine and waited too long to take my pills.

Thought it wouldn’t be a full-blown migraine and waited too long to take my pills.

Trudhesa: Count on It

Portrayal of a person with migraine

Trying to play with my kids but migraine pills only relieved
some of my pain.

Trying to play with my kids but migraine pills only relieved some of my pain.

Trudhesa: Count on It

Portrayal of a person with migraine

Running a meeting at work and my migraine pills still haven’t kicked in.

Running a meeting at work and my migraine pills still haven’t kicked in.

Trudhesa: Count on It

Trudhesa delivers relief you can count on
This one-of-a-kind nasal spray takes a shortcut to relief
Talk to your doctor about what’s not working. Trudhesa may be able to help
Proven migraine medication meets high-tech delivery
Product image of Trudhesa® Precision Olfactory Delivery (POD®) angled facing left on black background

Trudhesa® is the only migraine treatment that uses high-tech POD® technology to deliver trusted medication to the upper nasal space.

Trudhesa is proven to work at any time, so you can take it on your terms

Product image of Trudhesa® Precision Olfactory Delivery (POD®) vertical upright facing right

When 4515 migraine attacks were treated with Trudhesa in a 24-week safety study, exploratory results showed that for some people, Trudhesa was:

Icon of Trudhesa®
Speedy

Pain relief can start in as few as 15 minutes*

Icon of Trudhesa®
Steady

Pain freedom can last 2 days with just 1 dose*

Icon of Trudhesa®
At the ready

Designed to deliver relief time after time, even when taken late into an attack*

*Exploratory efficacy outcomes are based on patient reports and post hoc analyses from a phase 3, open-label safety study of Trudhesa.

Image of an actor portrayal of Trudhesa patient looking left down and smiling

Why Up the Nose

Serious or potentially life-threatening reductions in blood flow to the brain or extremities due to interactions between dihydroergotamine (the active ingredient in Trudhesa) and strong CYP3A4 inhibitors (such as protease inhibitors and macrolide antibiotics) have been reported rarely. As a result, these medications should not be taken together.
Indication
Trudhesa is used to treat an active migraine headache with or without aura in adults. Do not use Trudhesa to prevent migraine when you have no symptoms. It is not known if Trudhesa is safe and effective in children.
Do not use Trudhesa if you:
  • Have any disease affecting your heart, arteries, or blood circulation
  • Are taking certain anti-HIV medications known as protease inhibitors (such as ritonavir or nelfinavir)
  • Are taking a macrolide antibiotic such as clarithromycin or erythromycin
  • Are taking certain antifungals such as ketoconazole or itraconazole
  • Have taken certain medications such as triptans or ergot-type medications for the treatment or prevention of migraine within the last 24 hours
  • Have taken any medications that constrict your blood vessels or raise your blood pressure
  • Have severe liver or kidney disease
  • Are allergic to ergotamine or dihydroergotamine
Before taking Trudhesa, tell your doctor if:
  • You have high blood pressure, chest pain, shortness of breath, heart disease; or risk factors for heart disease (such as high blood pressure, high cholesterol, obesity, diabetes, smoking, strong family history of heart disease or you are postmenopausal, or male over 40); or problems with blood circulation in your arms, legs, fingers, or toes.
  • You have or had any disease of the liver or kidney.
  • You are taking any prescription or over-the-counter medications, including vitamins or herbal supplements.
  • You are pregnant, planning to become pregnant or are nursing, or have ever stopped medication due to an allergy or bad reaction.
  • This headache is different from your usual migraine attacks.

The use of Trudhesa should not exceed dosing guidelines and should not be used on a daily basis.

Serious cardiac (heart) events, including some that have been fatal, have occurred following the use of dihydroergotamine mesylate, particularly with dihydroergotamine for injection, but are extremely rare.

You may experience some nasal congestion or irritation, altered sense of taste, sore throat, nausea, vomiting, dizziness, and fatigue after using Trudhesa.

Contact your doctor immediately if you experience:

  • Numbness or tingling in your fingers and toes
  • Severe tightness, pain, pressure, heaviness, or discomfort in your chest
  • Muscle pain or cramps in your arms or legs
  • Cold feeling or color changes in 1 or both legs or feet
  • Sudden weakness
  • Slurred speech
  • Swelling or itching

The risk information provided here is not comprehensive. To learn more, talk about Trudhesa with your healthcare provider or pharmacist. The FDA-approved product labeling can be found at www.trudhesa.com or 1-800-555-DRUG. You can also call 1-833-TRUDHESA (1-833-878-3437) for additional information.